Total Payments
$11,529
2024 Payments
$1,571
Companies
54
Transactions
674
Medicare Patients
1,024
Medicare Billing
$68,810
Payment Breakdown by Category
Food & Beverage$11,462 (99.4%)
Education$67.33 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,462 | 661 | 99.4% |
| Education | $67.33 | 13 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,518 | 129 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,461 | 63 | $0 (2024) |
| Amgen Inc. | $1,162 | 52 | $0 (2024) |
| Novo Nordisk Inc | $971.35 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $569.88 | 38 | $0 (2024) |
| Amarin Pharma Inc. | $538.79 | 33 | $0 (2022) |
| Astellas Pharma US Inc | $495.74 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $458.93 | 27 | $0 (2022) |
| Forte Bio-Pharma LLC | $381.83 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $319.35 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,571 | 85 | AstraZeneca Pharmaceuticals LP ($401.31) |
| 2023 | $1,644 | 101 | AbbVie Inc. ($629.41) |
| 2022 | $2,038 | 112 | Novo Nordisk Inc ($365.74) |
| 2021 | $2,373 | 154 | AbbVie Inc. ($288.33) |
| 2020 | $1,083 | 79 | Amarin Pharma Inc. ($183.40) |
| 2019 | $847.89 | 38 | Astellas Pharma US Inc ($177.38) |
| 2018 | $1,124 | 55 | Amgen Inc. ($395.44) |
| 2017 | $848.52 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($222.38) |
All Payment Transactions
674 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.93 | General |
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $116.38 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PAIN | ||||||
| 10/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.26 | General |
| 09/11/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 698 | 1,546 | $104,193 | $44,995 |
| 2022 | 9 | 266 | 342 | $45,607 | $18,179 |
| 2021 | 2 | 31 | 52 | $9,632 | $3,264 |
| 2020 | 2 | 29 | 42 | $6,024 | $2,372 |
Total Patients
1,024
Total Services
1,982
Medicare Billing
$68,810
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 237 | 585 | $70,200 | $30,169 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 58 | $10,150 | $4,838 | 47.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 50 | $3,750 | $3,597 | 95.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 171 | 334 | $5,010 | $2,797 | 55.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $3,588 | $1,504 | 41.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 30 | 32 | $5,344 | $1,015 | 19.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 65 | $2,665 | $613.76 | 23.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 19 | 25 | $525.00 | $214.54 | 40.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 27 | 41 | $1,271 | $127.51 | 10.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 17 | $255.00 | $93.19 | 36.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 27 | 287 | $1,435 | $25.77 | 1.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 97 | $11,523 | $6,242 | 54.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 77 | $11,232 | $4,012 | 35.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 29 | 29 | $6,206 | $2,567 | 41.4% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 24 | 32 | $6,848 | $1,670 | 24.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $3,765 | $1,509 | 40.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 16 | 17 | $2,414 | $924.29 | 38.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $2,002 | $757.18 | 37.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $897.00 | $357.37 | 39.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 48 | $720.00 | $141.12 | 19.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 37 | $5,616 | $1,721 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 15 | $4,016 | $1,542 | 38.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 30 | $4,320 | $1,693 | 39.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 12 | $1,704 | $679.80 | 39.9% |
About Dr. Daniel Decamps, M.D
Dr. Daniel Decamps, M.D is a Family Medicine healthcare provider based in Lake City, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669578373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Decamps, M.D has received a total of $11,529 in payments from pharmaceutical and medical device companies, with $1,571 received in 2024. These payments were reported across 674 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($11,462).
As a Medicare-enrolled provider, Decamps has provided services to 1,024 Medicare beneficiaries, totaling 1,982 services with total Medicare billing of $68,810. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lake City, SC
- Active Since 09/16/2006
- Last Updated 05/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1669578373
Products in Payments
- FARXIGA (Drug) $1,075
- VRAYLAR (Drug) $806.35
- Vascepa (Drug) $538.79
- Ozempic (Drug) $523.64
- MYRBETRIQ (Drug) $444.41
- XARELTO (Drug) $416.74
- JARDIANCE (Drug) $340.90
- QULIPTA (Drug) $338.87
- Kerendia (Drug) $306.73
- Aimovig (Biological) $289.40
- XIFAXAN (Drug) $262.64
- UBRELVY (Drug) $248.78
- NURTEC ODT (Drug) $243.30
- Otezla (Drug) $240.59
- BREZTRI (Drug) $228.55
- NALOCET (Drug) $225.31
- Rybelsus (Drug) $197.40
- TRINTELLIX (Drug) $186.29
- Cologuard Collection Kit (Device) $173.80
- RYBELSUS (Drug) $173.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lake City
Miguel Tepedino, Md, MD
Family Medicine — Payments: $71,706
Family Medicine $71,706
Dr. Richard Wright, M.d, M.D
Family Medicine — Payments: $17,641
Family Medicine $17,641
Ernest De Leon, Md, MD
Family Medicine — Payments: $17,392
Family Medicine $17,392
Dr. David Moon, M.d, M.D
Family Medicine — Payments: $13,012
Family Medicine $13,012
Jean-Felert Cadet, M.d Mph, M.D MPH
Family Medicine — Payments: $5,750
Family Medicine $5,750
Dr. David Rodriguez, M.d, M.D
Family Medicine — Payments: $5,322
Family Medicine $5,322